Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer

1. Baselga, J.
2. Gómez, P.
3. Greil, R.
4. Braga, S.
5. Climent, M.A.
6. Wardley, A.M.
7. Kaufman, B.
8. Stemmer, S.M.
9. Pego, A.
10. Chan, A.
11. Goeminne, J.-C.
12. Graas, M.-P.
13. Kennedy, M.J.
14. Ciruelos Gil, E.M.
15. Schneeweiss, A.
16. Zubel, A.
17. Groos, J.
18. Melezínkova, H.
19. Awada, A.